INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC. FILES APPLICATION FOR "IDENTIFICATION OF MUC1-C AS A TARGET FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMAS"

GENEVA, Oct. 20 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215-5450) filed a patent application (PCT/US2025/024273) for "IDENTIFICATION OF MUC1-C AS A TARGET FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMAS" on Apr 11, 2025. With publication no. WO/2025/217515, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KUFE, Donald W. (c/o Dana-Farber Cancer Institute, Inc.450 Brookline AvenueBoston, Massachusetts 02215-5450)

Abstract: The present disclosure relates to a novel method of treating...